Pubfacts - Scientific Publication Data
  • Categories
  • Journals
  • ->
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:
Get 20% Off Journals at LWW.com

Analysis of fatal cases of pandemic influenza A (H1N1) virus infections in pediatric patients with leukemia.

Authors:
Yaman Yöntem Devrim Ilker Oymak Yeşim Türedi Ayşen Ozek Gülcihan Cartı Özgür Akçay Ciblak Meral Tatlı Güneş Burçak Demirağ Bengü Albudak Esin Badur Selim Vergin Canan

Pediatr Hematol Oncol 2013 Aug 22;30(5):437-44. Epub 2013 May 22.

Division of Pediatric Hematology, Dr. Behçet Uz Children's Hospital, İzmir, Turkey.

Background: Pandemic influenza A/H1N1/2009 virus usually causes mild illness in healthy children. Chronic medical conditions are recognized as increasing the risk for complications of influenza virus infection. Although most studies including children with acute leukemia and H1N1 virus have reported no deaths, some anectodal reports with low patient numbers have reported mortality rates as high as 28.5%. Here, we report patients with leukemia and H1N1 virus and review the literature.

Methods: Medical records of all children with leukemia and H1N1 virus in our institution were reviewed for demographic, clinical, and laboratory data. We also carried out a systematic review of the English-language literature. Among the 24 articles found, only patients with leukemia and pandemic H1N1 infections were reviewed by two independent reviewers.

Results: Eight of 98 children who received chemotherapy for leukemia were diagnosed with pandemic H1N1 infection. One developed pneumonia and acute respiratory distress syndrome (ARDS) and died. Another one developed hemophagocytic lymphohistiocytosis (HLH) and died due to secondary infection during the 6th week of treatment for HLH. In our study, 2 of 8 patients had a fatal course (25%), compared with an overall mortality of 2.5% in the studies retrieved from PubMed (6/232).

Conclusion: Pandemic H1N1 influenza virus caused mortality in patients with ARDS or HLH; an unexpected finding for pandemic H1N1 (2009) influenza virus. Thus, for children with leukemia and infected with H1N1 virus, short- and long-term complications should be kept in mind during evaluation.

Download full-text PDF

Source
http://dx.doi.org/10.3109/08880018.2013.796025DOI Listing
August 2013

Publication Analysis

Top Keywords

h1n1 virus
20
pandemic h1n1
16
leukemia h1n1
12
patients leukemia
12
influenza virus
12
virus
9
h1n1
9
children leukemia
8
pandemic influenza
8
leukemia
7
pandemic
6
children
5
patients
5
influenza
5
diagnosed pandemic
4
infection developed
4
h1n1 infection
4
leukemia diagnosed
4
hemophagocytic lymphohistiocytosis
4
received chemotherapy
4

Similar Publications

Clinical features and outcomes of influenza by virus type/subtype/lineage in pediatric patients.

Authors:
Seung Beom Han Jung-Woo Rhim Jin Han Kang Kyung-Yil Lee

Transl Pediatr 2021 Jan;10(1):54-63

Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Background: Recently, four influenza viruses are circulating worldwide: A(H1N1)pdm09, A(H3N2), B/Victoria, and B/Yamagata. However, information on the clinical differences among pediatric patients infected with four recently circulating influenza viruses is sparse.

Methods: Medical records of pediatric patients (<20 years of age) diagnosed with influenza between the 2014-2015 and 2018-2019 influenza seasons were retrospectively reviewed. Read More

View Article and Full-Text PDF
January 2021
Similar Publications

Evolutionary conservation of the DRACH signatures of potential N6-methyladenosine (mA) sites among influenza A viruses.

Authors:
Mahmoud Bayoumi Muhammad Munir

Sci Rep 2021 Feb 25;11(1):4548. Epub 2021 Feb 25.

Division of Biomedical and Life Sciences, Lancaster University, Lancaster, LA1 4YG, UK.

The addition of a methyl group to the N6-position of adenosine (mA) is considered one of the most prevalent internal post-transcriptional modifications and is attributed to virus replication and cell biology. Viral epitranscriptome sequencing analysis has revealed that hemagglutinin (HA) mRNA of H1N1 carry eight mA sites which are primarily enriched in 5'-DRACH-3' sequence motif. Herein, a large-scale comparative mA analysis was conducted to investigate the conservation patterns of the DRACH motifs that corresponding to the reference mA sites among influenza A viruses. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Performance of BioFire array or QuickVue influenza A + B test versus a validation qPCR assay for detection of influenza A during a volunteer A/California/2009/H1N1 challenge study.

Authors:
David R McIlwain Han Chen Maria Apkarian Melton Affrime Bonnie Bock Kenneth Kim Nilanjan Mukherjee Garry P Nolan Monica M McNeal

Virol J 2021 Feb 25;18(1):45. Epub 2021 Feb 25.

Department of Pediatrics, University of Cincinnati College of Medicine, Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Background: Influenza places a significant burden on global health and economics. Individual case management and public health efforts to mitigate the spread of influenza are both strongly impacted by our ability to accurately and efficiently detect influenza viruses in clinical samples. Therefore, it is important to understand the performance characteristics of available assays to detect influenza in a variety of settings. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Comprehensive N-glycosylation analysis of the influenza A virus proteins HA and NA from adherent and suspension MDCK cells.

Authors:
Alexander Pralow Marcus Hoffmann Terry Nguyen-Khuong Markus Pioch René Hennig Yvonne Genzel Erdmann Rapp Udo Reichl

FEBS J 2021 Feb 24. Epub 2021 Feb 24.

Max Planck Institute for Dynamics of Complex Technical Systems, Sandtorstrasse 1, 39106, Magdeburg, Germany.

Glycosylation is considered as a critical quality attribute for the production of recombinant biopharmaceuticals such as hormones, blood clotting factors or monoclonal antibodies. In contrast, glycan patterns of immunogenic viral proteins, which differ significantly between the various expressions systems, are hardly analyzed yet. The influenza A virus (IAV) proteins hemagglutinin (HA) and neuraminidase (NA) have multiple N-glycosylation sites, and alteration of N-glycan micro- and macroheterogeneity can have strong effects on virulence and immunogenicity. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Antiviral activity and mechanism of ESC-1GN from skin secretion of hylarana guentheri against influenza a virus.

Authors:
Jie Yang Bei Zhang Yingna Huang Teng Liu Baishuang Zeng Jingwei Chai Jiena Wu Xueqing Xu

J Biochem 2021 Feb 24. Epub 2021 Feb 24.

Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China.

Development of new and effective anti-influenza drugs is critical for prophylaxis and treatment of influenza A virus infection. A wide range of amphibian skin secretions have been identified to show antiviral activity. Our previously reported ESC-1GN, a peptide from the skin secretion of Hylarana guentheri, displayed good antimicrobial and anti-inflammatory effects. Read More

View Article and Full-Text PDF
February 2021
Similar Publications
Save 15% Survey
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap